What are the main modes of onset of type 1 diabetes?
Type 1 diabetes can begin in several ways, the main difference being how quickly pancreatic beta cell function is lost. The most common forms of onset are: classic onset with typical symptoms (frequent urination, intense thirst, weight loss), onset with diabetic ketoacidosis, silent onset discovered incidentally on routine blood tests, and slow onset observed in some adults [1].
The form of onset depends greatly on age. In children and adolescents, onset is usually rapid and dramatic, compared with adults, in whom symptoms can develop gradually, over the course of months or years. Early recognition of the symptoms greatly reduces the risk of a severe onset with ketoacidosis, as the figure below shows [1].
The four ways type 1 diabetes begins
- Classic onsetThirst, frequent urination, weight lossThe best known form. The symptoms settle in over a few weeks.
- Onset with ketoacidosisNausea, deep breathing, drowsinessA medical emergency. It happens when the lack of insulin is severe.
- Silent onsetFound on a routine testBlood glucose is high, but symptoms are absent or go unnoticed.
- Slow onsetMonths-long course, mostly in adultsThe beta cells are lost gradually, and at first the disease can be mistaken for type 2.
What is onset with diabetic ketoacidosis?
Diabetic ketoacidosis is a serious, life-threatening acute complication. It occurs when insulin deficiency becomes so severe that the body starts to use fats as its main energy source. Ketone bodies start to accumulate in the blood, where, being acidic, they alter the body's acid-base balance. Ketoacidosis is defined by three criteria occurring together:
- blood glucose ≥200 mg/dL (≥11.1 mmol/L);
- elevated ketone bodies (beta-hydroxybutyrate ≥3.0 mmol/L);
- metabolic acidosis — pH below 7.3 or bicarbonate below 18 mmol/L [2].
Symptoms include nausea, vomiting, abdominal pain, rapid and deep breathing, the smell of acetone on the breath, marked dehydration and sometimes altered consciousness. Ketoacidosis at onset is a medical emergency and requires immediate hospitalization. If you suspect ketoacidosis — intense thirst, labored breathing, nausea or vomiting, drowsiness — go to the emergency room straight away, do not wait for an appointment. Approximately three in ten children and adolescents with newly diagnosed type 1 diabetes present with ketoacidosis, with wide variation between countries, and children with a family history have an even higher risk of severe onset [3].
What does "classic" onset mean?
"Classic" onset refers to the appearance of the typical symptoms of uncontrolled diabetes. The hyperglycemic triad consists of frequent urination in large amounts (polyuria), intense and persistent thirst (polydipsia) and unintentional weight loss. To these are often added fatigue, blurred vision, excessive hunger and, in children, a return of bedwetting at night (enuresis). These symptoms appear when blood glucose exceeds the renal threshold, usually around 180 mg/dL (10 mmol/L), though it differs from one person to another. Above this threshold, glucose in the blood begins to be eliminated through the urine, dragging water from the body along with it [4].
Symptoms usually develop over a few weeks, and sometimes even within just a few days. Recognizing them is essential because it allows rapid diagnosis and the initiation of life-saving insulin treatment, before the patient enters ketoacidosis. If you notice this combination of symptoms in yourself or in a family member, it is important to see a doctor as soon as possible for a blood glucose check. A simple finger-prick test can raise the suspicion of diabetes, but the diagnosis is confirmed by laboratory testing, according to the diagnostic criteria [4].
How often does silent onset occur?
Silent onset means discovering diabetes without dramatic symptoms, through routine blood tests or screening programs. It occurs much more rarely than classic onset or onset with ketoacidosis. It is seen especially in adults and in first-degree relatives of a person with type 1 diabetes. It is also found in people who take part in screening studies for pancreatic autoantibodies. In these people, blood glucose may be only mildly elevated, and testing thus discovers the disease at an early stage [5].
Early detection, before severe symptoms appear, allows treatment to be started before the patient develops ketoacidosis. It also provides time for therapeutic education and protects the pancreatic beta cells that are still working. This type of onset highlights the value of periodic testing for close relatives of people with type 1 diabetes. Testing matters most for children and young people with a family history and genetic predisposition (HLA, human leukocyte antigen) [6].
How fast does type 1 diabetes begin: suddenly or gradually?
Yes, type 1 diabetes can follow two patterns of clinical evolution. Acute onset appears within a few days or weeks and reflects a rapid loss of insulin production. This pattern is characteristic of children and adolescents, in whom symptoms set in suddenly and can quickly lead to ketoacidosis. Slow onset is observed especially in adults and unfolds over the course of several months or even years. Symptoms are less intense and the loss of pancreatic beta cell function is gradual [1].
The slow form, seen in adults, is sometimes called latent autoimmune diabetes in adults (LADA). These people may initially appear to have type 2 diabetes and may respond temporarily to oral medications, but eventually progress to insulin dependence. Correct identification of the type of onset is important because it directly influences the treatment plan and the moment when insulin is started [7].
At what age does type 1 diabetes most often begin?
Type 1 diabetes can occur at any age, from the first year of life to advanced old age, but there are two typical incidence peaks in children. The first peak appears between 4 and 6 years, and the second, more pronounced, between 10 and 14 years, during puberty. These stages correspond to hormonal and immunological changes that can accelerate the destruction of pancreatic beta cells [8].
Although it was traditionally considered a disease of childhood, the incidence peaks are in childhood, at 4–6 and 10–14 years of age, but the absolute number of new cases diagnosed in adulthood is greater, because adult life covers many more decades. In adults, onset can appear at any time and is sometimes misdiagnosed as type 2 diabetes. Thus, age at diagnosis is no longer a sufficient criterion for establishing the type of diabetes. Assessment of the clinical picture is also needed, where appropriate together with additional tests such as pancreatic autoantibodies and C-peptide [9].
How does onset differ in young children compared with adolescents and adults?
In young children, under 5 years, onset is the most rapid and the most severe. Symptoms set in within a few days, and the risk of ketoacidosis at diagnosis is the highest. Young children cannot clearly express thirst or fatigue, and severe dehydration and vomiting can be confused with gastroenteritis. In adolescents, the classic symptoms are easier to recognize but can be masked by the natural changes of puberty or by weight loss attributed to growth [1].
In adults, onset is usually slower, with moderate symptoms that evolve over weeks or months. Adults can preserve a residual insulin production that temporarily protects them from ketoacidosis. For this reason many adults are misdiagnosed as having type 2 diabetes. This explains why in adults (especially younger ones) the diagnosis should not rely on age alone. Specific tests are also needed, which can bring to light the autoimmune nature of the disease [10].
What triggering factors can precipitate clinical onset?
In people who already have pancreatic autoantibodies and a partial loss of beta cell function, certain factors can accelerate the transition to clinically manifest disease. The best-known triggering factors are viral infections, such as enterovirus infections (especially Coxsackie B) and SARS-CoV-2 infection. Intense physical stress, major trauma, surgical interventions and puberty can also hasten onset [11].
Certain medications, such as corticosteroids, can precipitate ketoacidosis in vulnerable people who are already on their way towards type 1 diabetes onset. Intense psychological stress is also considered a possible aggravating factor. It is important to understand that these factors are not the cause of type 1 diabetes. They only accelerate the clinical manifestation of an autoimmune disease that is already present, which had been evolving silently for months or even years. Most likely, the disease would have become clinically manifest even without these factors, only later [11].
Is hospitalization needed at onset?
Usually yes, especially in children. At the onset of type 1 diabetes, hospitalization is usually necessary, especially in children and adolescents, and it becomes all the more important if vomiting develops. Hospitalization allows metabolic stabilization, correction of dehydration and electrolyte imbalances, the safe initiation of insulin therapy and therapeutic education for you and your family. In patients who present with ketoacidosis, hospitalization, sometimes even in the intensive care unit, is mandatory [12].
If you only have hyperglycemia, without ketoacidosis, without severe dehydration and with moderate symptoms, treatment can be started on an outpatient basis. This is the case in some adults with slow onset, provided there is close supervision and rapid access to specialists. Wherever treatment begins, the initial period includes learning how to administer insulin, recognizing hypoglycemia, monitoring blood glucose and the basic principles of nutrition for type 1 diabetes. This initial education is the foundation for good long-term control [12].
How quickly should insulin therapy be started after diagnosis?
Insulin therapy should be started as quickly as possible after diagnosis, ideally on the same day type 1 diabetes is confirmed. In patients who present with ketoacidosis, insulin is given intravenously, together with the measures for correcting dehydration and electrolyte imbalances, according to standard protocols. In patients without ketoacidosis, insulin is started directly subcutaneously, in doses adjusted to weight and to the blood glucose value [13].
Early initiation of insulin rapidly removes the acute symptoms, prevents progression to ketoacidosis and helps preserve the function of residual beta cells. Preserved residual beta cell function is associated with better long-term glycemic control. In adults with slow onset, insulin is sometimes introduced too late into the treatment plan. Prolonged use of oral medications alone can then lead to metabolic deterioration, including in the long term. That is why early identification of type 1 diabetes in adults is essential for a good prognosis [13].
Conclusions
- Type 1 diabetes has four main forms of onset: classic, with ketoacidosis, silent and slow [1].
- Approximately three in ten children and adolescents are diagnosed during an episode of diabetic ketoacidosis, defined by blood glucose ≥200 mg/dL, beta-hydroxybutyrate ≥3.0 mmol/L and pH<7.3 [2] [3].
- The incidence peaks in children are at 4–6 years and 10–14 years, but the absolute number of new cases diagnosed in adulthood is greater, because adult life covers many more decades [8] [9].
- Insulin therapy should be started as quickly as possible, ideally on the day of diagnosis, to prevent ketoacidosis and preserve pancreatic beta cell function [13].
You might also be interested in
Other pages about the diagnosis and staging of type 1 diabetes.
Type 1 diabetes diagnosis
Stages of progression of type 1 diabetes
Glossary terms used here
- onset
- onset with ketoacidosis
- diabetic ketoacidosis
- type 1 diabetes
- diabetes mellitus
- beta cells
- classic onset
- ketone bodies
- blood glucose
- dehydration
- polyuria
- polydipsia
- glucose
- diagnostic criteria
- screening
- autoantibodies
- genetic predisposition
- LADA
- incidence
- C-peptide
- enteroviruses
- stress
- insulin therapy
- hyperglycemia
- hypoglycemia
- psychological impact
- glycated hemoglobin (HbA1c)
- HbA1c
References
- The pathophysiology, presentation and classification of Type 1 diabetes. Diabetes Obes Metab. 2025;27(Suppl 6):15-27. PubMed
- Hyperglycemic Crises in Adults With Diabetes: A Consensus Report. Diabetes Care. 2024;47(8):1257-1275. PubMed
- Exploring the severity and early onset of familial type 1 diabetes in Romania: genetic and microbiota insights. Arch Clin Cases. 2024;11(1):29-33. PubMed
- 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(Suppl 1):S27-S49. PubMed
- Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care. 2015;38(10):1964-1974. PubMed
- Association of HLA Haplotypes with Autoimmune Pathogenesis in Newly Diagnosed Type 1 Romanian Diabetic Children: A Pilot, Single-Center Cross-Sectional Study. Life (Basel). 2024;14(6):781. PubMed
- Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel. Diabetes. 2020;69(10):2037-2047. PubMed
- The Changing Epidemiology of Type 1 Diabetes: A Global Perspective. Diabetes Obes Metab. 2025;27(Suppl 6):3-14. PubMed
- Global type 1 diabetes prevalence, incidence, and mortality estimates 2025: Results from the International Diabetes Federation Atlas, 11th Edition, and the T1D Index Version 3.0. Diabetes Res Clin Pract. 2025;225:112277. PubMed
- Type 1 diabetes presenting in adults: Trends, diagnostic challenges and unique features. Diabetes Obes Metab. 2025;27(Suppl 6):57-68. PubMed
- The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus. Nat Rev Endocrinol. 2024;20(10):588-599. PubMed
- ISPAD clinical practice consensus guidelines 2022: Diabetic ketoacidosis and hyperglycemic hyperosmolar state. Pediatr Diabetes. 2022;23(7):835-856. PubMed
- International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Insulin and Adjunctive Treatments in Children and Adolescents with Diabetes. Horm Res Paediatr. 2024;97(6):584-614. PubMed